Hayman LL, Meininger JC, Daniels SR, McCrindle BW, Helden L, Ross J, et al. Primary prevention of cardio-vascular disease in nursing practice: Focus on children and youth: A scientific statement from the American Heart Association Committee on Atherosclerosis, Hyper-tension, and Obesity in Youth of the Council on Cardio-vascular Disease in the Young, Council on Cardiovascu-lar Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabo-lism. Circulation 2007; 116
Weiss R, Dziura J, Burgert TS. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med 2002; 346: 854-5.
Strauss RS, Pollack HA. Epidemic increase in childhood overweight. 1986–1998. JAMA 2001; 286: 2845-48.
Reilly JJ, Dorosty AR. Epidemic of obesity in UK chil-dren. Lancet 1999; 354: 1874-5.
Baba R, Nagashima M, Asai T, Kato Y. Effect of physical activity and readiness for exercise on the development of obesity in adolescents (in Japanese). Jpn J Clin Sports Med 2004; 12: 346-51.
Baba R, Koketsu M, Nagashima M, Inasaka H, Yoshi-naga M, Yokota M. Adolescent obesity adversely affects blood pressure and resting heart rate. Circ J 2007; 71: 722-6.
Baba R, Iwao N, Iwao S, Koketsu M, Nagashima M, Inasaka H. Risk of obesity enhanced by poor physical ac-tivity in high school students. Pediatr Int 2006; 48: 268-73.
DeFronzo RA, Ferrannini E. Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hy-pertension, dyslipidemia, and atherosclerotic cardiovas-cular disease. Diabetes Care 1991; 14: 173-94.
Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Clin Endocrinol Metab 2002; 87: 3023-8.
Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obe-sity-associated hypertension: new insights into mecha-nisms. Hypertension 2005; 45: 9-14.
Hall JE, Hildebrandta DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hy-pertens 2001; 14 (suppl 1): S103-15.
Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepati-tis) and obesity: An autopsy study with analysis of risk factors. Hepatology 2005; 12: 1106-10.
Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syn-drome X in severe obesity. J Clin Endocrinol Metab 1999; 84:1513-7.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver dis-ease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-72.
Wellen KE, Hotamisligil GS.Obesity-induced inflamma-tory changes in adipose tissue. J Clin Invest 2003; 112: 1785-8.
Lee YH, Pratley RE, The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005; 5: 70-5.
Falcon C, Pfliegler G, Deckmyn H, Vermylen J. The platelet insulin receptor: Detection, partial characteriza-tion, and search for a function. Biochem Biophys Res Commun 1988; 157: 1190-6.
Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents: Studies in vitro and in vivo. Dia-betes 1988; 37: 780-6.
Westerbacka J, Yki-J?rvinen H, Turpeinen A, Rissanen A, Vehkavaara S, Syrj?l? M, et al. Inhibition of plate-let-collagen interaction: An in vivo action of insulin abol-ished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol 2002; 22: 167-72.
Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. Clin Endo-crinol Metab 2007; 92: 4569-74.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establish-ing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320:1240-3.
Festa A, D'Agostino R Jr, Howard G, Mykk?nen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Re-sistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-7.
Wilson CA, Bekele G, Nicolson M, Ravussin E, Prat-leyRE. Relationship of the white blood cell count to body fat: role of leptin. Br J Haematol 2003; 99: 447-51.
Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Cir-culation 1991; 84: 613-7.
Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, et al. Platelet count is independently associ-ated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2003; 52: 1246-9.
Falcon CR, Cattaneo M, Ghidoni A, Mannucci PM. The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentra-tions of ionized calcium. Thromb Haemost 1993; 70: 389-92.
Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr 2002; 140: 660-6.